Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 30

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 16
Chunk 30
---

    (27,580
    )

    (33,131
    )

    (24,534
    )

    Cash flows from financing activities

    Proceeds from credit facilities

    197,600

    174,500

    —

    Repayment of borrowings from credit facilities

    (142,500
    )

    (79,000
    )

    —

    Payment of debt acquired from SeaSpine merger

    —

    (26,899
    )

    —

    Proceeds from issuance of common shares

    6,257

    5,127

    4,337

    Payments related to withholdings for share-based compensation

    (5,312
    )

    (4,397
    )

    (1,729
    )

    Payment of contingent consideration

    (1,000
    )

    (1,000
    )

    —

    Payments related to finance lease obligation

    (706
    )

    (652
    )

    (2,594
    )

    Payment of debt issuance costs and other financing activities

    (3,630
    )

    (2,357
    )

    (92
    )

    Net cash provided by (used in) financing activities

    50,709

    65,322

    (78
    )

    Effect of exchange rate changes on cash and restricted cash

    (938
    )

    619

    (997
    )

    Net change in cash, cash equivalents, and restricted cash

    47,981

    (12,943
    )

    (37,147
    )

    Cash, cash equivalents, and restricted cash at the beginning of the year

    37,757

    50,700

    87,847

    Cash, cash equivalents, and restricted cash at the end of the year
     
    $
    85,738

    $
    37,757

    $
    50,700

    Components of cash, cash equivalents, and restricted cash at the end of the year

    Cash and cash equivalents
     
    $
    83,238

    $
    33,107

    $
    50,700

    Restricted cash

    2,500

    4,650

    —

    Cash, cash equivalents, and restricted cash at the end of the year
     
    $
    85,